CD33 and hepatocellular carcinoma: Zhou et al42 showed the CD11b+CD33+HLA‐DR−MDSCs was upregulated in both peripheral blood and intratumor tissues and could inhibit CD8+ T‐cell proliferation in patients with HCC.